Pharmacologic Class Information
|Pharmacologic Name||Increased Epithelial Proliferation|
|Pharmacologic Concept||Physiologic Effects - [PE]|
|Pharmacologic Concept Description||This concept refers to the tissue, organ, or organ system effects of drug generic ingredients, organized into an organ system classification hierarchy, beneath the "Physiological Effects [PE]" concept.|
NDC Products with Increased Epithelial Proliferation
The table contains 1 products whose active ingredient are classified under the same pharmacologic class Increased Epithelial Proliferation [PE].
|NDC||Proprietary Name||Non-Proprietary Name||Dosage Form||Route Name||Company Name||Status|
|66658-113||Kepivance||Non-Proprietary Name: Palifermin||Injection, Powder, Lyophilized, For Solution||Intravenous||Swedish Orphan Biovitrum Ab (publ)||ACTIVE|